Brands
Our expertise in cultivation fuels patient wellbeing, delivering CBPMs across distinct medicinal cannabis brands to cater to diverse consumer segments and improve accessibility. This dual-brand strategy widens access and maximises therapeutic impact. CINV’s mission is straightforward: use our resources for the direct betterment of patient health with CBPMs, serving varied needs and ensuring affordability.
Ember Pharms
Ember Pharms is a wholly-owned subsidiary of CINV. CINV plans for Ember Pharms to be the only EU-GMP-certified extraction facility in South Africa, enabling additional revenue from processing third-party flowers into oils for export. It is also the name of one of our wholly-owned brands of medical cannabis. Under the Ember Pharms brand, we prioritise affordability without compromising on quality, offering medical cannabis strains with high cannabinoid and terpene profiles at accessible prices for patients.
